US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Veidekke ASA (0GF6) 銘柄情報

Veidekke ASA (0GF6)

0.00

0.00

(0.00%)

終了 6月15日 12:30AM

Veidekke ASA (0GF6) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

-

( - )

買値

-

売値

-

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

-

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

£ 88,117

発行済株式数

135,380,944

配当利回り

11.25 (6.24%)

PER

15.92

1 株当たり利益 (EPS)

11.32

歳入

43.76B

純利益

1.59B

Veidekke ASA operates as a construction and property development company in Norway, Sweden, and Denmark. It operates through Construction Norway, Infrastructure Norway, Construction Sweden, Infrastructure Sweden, and Denmark/Hoffmann segments. The company engages in construction of commercial buildi... Veidekke ASA operates as a construction and property development company in Norway, Sweden, and Denmark. It operates through Construction Norway, Infrastructure Norway, Construction Sweden, Infrastructure Sweden, and Denmark/Hoffmann segments. The company engages in construction of commercial buildings such as offices, hotels, warehouses and other logistics buildings for the private sector, as well as schools, healthcare facilities and other public buildings; infrastructure operations of public transport projects such as roads, railways and airports, power generation facilities, water supply and sewerage, foundations, road maintenance, asphalting, deliveries of aggregates, and landfill services; and renovation of public, commercial and residential buildings. It also offers asphalt products, including environmental, low-temperature, and colored asphalt. The company was founded in 1936 and is headquartered in Oslo, Norway. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.veidekke.com

本社

Oslo, Norway

設立

2026

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

0GF6 - Frequently Asked Questions (FAQ)

What is the current Veidekke ASA share price?

The current share price of Veidekke ASA is £ 0.00

How many Veidekke ASA shares are in issue?

Veidekke ASA has 135,380,944 shares in issue

What is the 1 year trading range for Veidekke ASA share price?

Veidekke ASA has traded in the range of £ 0.00 to £ 0.00 during the past year

What is the PE ratio of Veidekke ASA?

The price to earnings ratio of Veidekke ASA is 15.92

What is the cash to sales ratio of Veidekke ASA?

The cash to sales ratio of Veidekke ASA is 0.56

What is the registered address of Veidekke ASA?

The registered address for Veidekke ASA is Standardveien 28B, Oslo, Oslo, 0581

What is the Veidekke ASA website address?

The website address for Veidekke ASA is www.veidekke.com

GetSeriousOK

GetSeriousOK 4分前

Seriously, you're pretending that the patents aren't expired? You know better.

And why do you care? Nobody else cares whether BIEL's devices are patented or not. Mayer doesn't care, so why do you?

If somebody other than Mayer wanted to get generic devices from CICD Shen

Investor082

Investor082 6分前

Yup, a bunch of BS artists. But it tells you LP has nothing meaningful up her sleeve and endless dilution in pennies is going to continue for months and years. Easy money for LP’s financiers to play both ways and anyone that wants to bet against false promises and expectations they set moving forwar

Eli's Gone

Eli's Gone 6分前

I'm in: 11-19-5-43

Eli's Gone

Eli's Gone 6分前

theorysuit

theorysuit 6分前

FDA already told them no and would have rejected them on the spot with no chance of appeal as the uK allows. They are hiding out appealing the UK rejection almost 3 years later. LP said they won't update on the UK submission ....lmfao at this POS

surfkast

surfkast 7分前

Sadly the OTC King was basically a king in his own mind. Three of his companies are dark. His Canadian scammer buddy Luis Sapi is promoting the VitaCaeli Emergency Use Resuscitator through dark FORW which is also defunct EM! Good luck getting the current anytime soon. The claim is a US patent ha

theorysuit

theorysuit 9分前

It's obvious they cant submit the FDA but you are bursting the pipedreams of the FDA for the pump crew. This company has nothing

Investor082

Investor082 9分前

LOL, only LP to blame, but she loves excuses and playing a victim card! ;)

US Market News

US Market News 9分前

AV Introduces TOM 50 RE, a Backpackable UGV for Rapid Reconnaissance and Explosive Ordnance DisposalJune 14, 2026 11:45 AM
Business Wire Lightweight uncrewed ground vehicle expands mission flexibility for highly mobile units operating in complex and contested e

Vexari

theorysuit

theorysuit 10分前

It's funny. The few things LP does say and the pumpers accuse you of her or Lg never saying things like multiple submissions or direct restart or they are on the last mile 10 years ago. Nwbo pays people to refute what they said ....lmfao pathetic.

HyGro

No Rx Co. views UK as an attractive market. Industry and trade-policy analyses frame the U.S. as the primary profit engine for global pharma, with European markets like the UK viewed more as volume and reference-pricing anchors than drivers of economic rent.
Large manufacturers have explicit

cableguy

cableguy 11分前

So what??? NO BUDDY CARES HERE IN THE SWAMP CELLAR they all go up when the news is good, you guys do this all the time, really what you are doing is SELF BLOVIATION & SELF GRATIFCATION why do you feel the need to do this, that's a mental health issue, IHUB aught to offer Psychiatrist to help. thats

Investor082

Investor082 12分前

Liar! But enjoy the endless dilution in pennies! ;)

tredenwater2

tredenwater2 14分前

Dr Missling is advertising for a new position at a small biotech through these postings imo. This may be a good sign to come once the current CEO settles the final severance payout.

3331

BIEL #1 on the Breakout Board and #1 Most Read Board the past 24 hours! Better than the SpaceX IPO!
https://i.postimg.cc/prCCScR0/BCO-4fc70e99-1e43-4669-9c94-51c39deb7670.png

learningcurve2020

learningcurve2020 16分前

She also knew MHRA approval requires a web of various groups chiming in, and is going through massive flux do to politics and financial constraints. 🤷‍♀️

BBANBOB

BBANBOB 18分前

Tepper alone supposedly has about 86 bill coming back to HIM ALONE if even the smaller of the BIG $ guesses are wrong and I can assure you he would fight for that........

NOW there has been speculation by many that SOME SORT OF SIDE deal was made with DA BOYZ not sure how that could b

Flip it

Flip it 18分前

https://www.tipranks.com/news/heres-why-top-b-riley-analyst-raised-marvell-mrvl-stock-price-target-by-more-than-40

Sunnybank

Sunnybank 18分前

Thought he had a perfect game going. Sucks either way. Schlittler hung tough and got the win. Went deep enought to lower his ERA. Our AllStar game starters perhaps.

Sunnybank

Sunnybank 18分前

Thought he had a perfect game going. Sucks either way. Schlittler hung tough and got the win. Went deep enought to lower his ERA. Our AllStar game starters perhaps.

3331

BIEL #1 on the Breakout Board and #1 Most Read Board the past 24 hours! Better than the SpaceX IPO!
https://i.postimg.cc/prCCScR0/BCO-4fc70e99-1e43-4669-9c94-51c39deb7670.png

learningcurve2020

learningcurve2020 19分前

Your thinking is what’s warped. It’s called HAVING A TRACK RECORD OF SUCCESS. Musk has all the right stuff including solid patents. Next he’ll invent a cryo facility to store humans until a cure is found. Btw, what do you think SpaceX’s value would be if their facility was owned by the Chinese?

surfkast

surfkast 20分前

Nothing can be done until there is a reading of the will which I am betting there is one. So stop the nonsense. Plus this is a known worthless shell due to the SEC and too many other issues.
Try posting facts. Thanks.

HyGro

FDA cost more (est. $1.2 million) but the value of the approval is so much more valuable because U.S. approval opens the most profitable market in the world. Approval in the UK is likely going to be unprofitable for NWBO as pricing is so low due to NICE.

Canoe Asset Allocation P...

Verizon Communications

Primary Health Prop

Portage Biotech

JP Morgan Dividend Leade...

Thungela Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。